https://www.barrons.com/articles/amgen-stock-revenue-guidance-588fb134
0
0
10/31/23 at 3:13pm
Organization
Barron's
Author
Emily Dattilo
30 words
0
Comments
Amgen stock fell Tuesday even after the biotechnology company easily beat quarterly earnings estimates and raised revenue guidance.
You are the first to view
Create an account
or login to join the discussion